SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Stock Swap -- Ignore unavailable to you. Want to Upgrade?


To: Trader X who wrote (13711)5/8/1998 11:24:00 AM
From: Big Brother  Read Replies (1) | Respond to of 17305
 
Hi, TX man! Would you have time to look at the 1st support point for CPQ?
i.e. The point at which, if it goes lower, I should maybe sell.

Thanks, Todd



To: Trader X who wrote (13711)5/8/1998 11:48:00 AM
From: Andrew Vance  Respond to of 17305
 
*AV*--Just a great deal of neglect maybe. For the keck of it, look at SUGN as I mentioned before. If ENMD is/was so great why has a company who has a competitive product that is already in human trials, not taken off as ENMD did. Selectivity is the only answer.

Payment of the patent agreement by IVAX netted $3.2M for NPRO which was about the time it rose above $3 for a fraction of a day<GG> and they ended their marketing agreement with IVAX.

This is not a stock for everyone and is quite different from ENMD. ENMD was a shorter's dream due to herd mentality at the open. Comparing volumes traded on ENMD pre and post 5/1/98 clear;y shows a herd mentality and not a good investment. I think NPRO could pop when it is discovered due to the same type of mentality, though it won't run away like ENMD did. The other thing I like is the company. It is locate locally and when I go out to restaurants or to some gatherings you can't help but overhear the zealous conversations about what is in store down the road. It almost appears to be that red tape is holding this company back a bit and that they are navigating through a sea of red tape.

Andrew